搜索
产品
社区
市场
新闻
经纪商
更多
CN
开始
Genmap Correction -40 %
做多
Genmab A/S
(
NASDAQ:GMAB
)
Softclick-Capital
Essential
NASDAQ:GMAB
Genmab A/S
Trend Analysis
genmab
biotech
crash
1
2
trendanalysis
genmab
biotech
crash
I like Genmab. The stock was one of my long positions for many years. I went into cash in the fall of 2021. After minus 40 percent, I will now gradually add to Genmab again.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在
使用条款
阅读更多信息。